Sort by
Refine Your Search
-
Employer
-
Field
-
globally to collaborate in diagnosis and research in NMD. Our aim is to improve international knowledge of the global causes of NMD and increase access to genomic medicine, so more patients’ care can be
-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress
-
international CANCAN Cancer Grand Challenge Team. Prof. Mariam Jamal-Hanjani is Principal Investigator of the TRACERx study at UCL, Chief Investigator of the PEACE study and a co-PI within the international
-
short-read, long-read, and transcriptome data. There is also the potential to develop and publish novel analytical approaches. This is a unique opportunity to work alongside clinical experts
-
a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs ) and search using vacancy reference B02-10144. To apply, please upload a current
-
part-time, flexible, and job share basis wherever possible. This appointment is subject to UCL Terms and Conditions of Service for Research and Professional Services Staff. Please visit https